Delivery Order SPE2DB24D1205-SPE2DB25FCXWC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 per unit, with a ceiling value of $12,891.33. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 tablets, with a ceiling value of $2,915.55. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $13,063.67 with firm fixed pricing, represents a pharmaceutical procurement under the agency's medical supply chain operations. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and...
- The Defense Logistics Agency awarded a $44,543.69 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $23,354.50 and an ultimate completion date of September 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $21,872.95. This competitively awarded, firm fixed-price delivery order is set to be completed by July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract is valued at $63,889.39 and is classified as a firm fixed price delivery order with an ultimate completion date of September 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitive award, valued at $10,669.37 with firm fixed pricing, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of July 24, 2025. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a ceiling value of $6,140.30 and a completion date of June 3, 2025. This competitive award, which utilized no set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is the...
- The Defense Logistics Agency awarded a $20,861.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The work is scheduled for completion by August 1, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXWCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a ceiling value of $17,848.57. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under a larger indefinite delivery vehicle that enables the company to supply pharmaceutical products to support federal healthcare programs. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, fulfilling critical medication needs across military and veteran healthcare systems. The company holds a significant prime indefinite delivery contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which establishes the framework for delivering a comprehensive range of pharmaceutical products globally. Through competitive procurement processes, AmerisourceBergen demonstrates its capability to meet federal medical supply requirements for various therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities with specialized medications, brand-name and generic drugs, vaccines, and related medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 6/18/25 |